ArticleFrontiers in oncology2022

Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells.

Wen Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.